Clinical Trial Update: Mitochondrial Methylation in Type 2 Diabetes

View source ↗

Summary

A University of Arizona trial studying mitochondrial methylation in metabolic conditions (overweight/obesity and Type 2 diabetes) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Arizona | Conditions: Overweight, Obesity | Status: COMPLETED